Design &amp; rationale of the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) (Q73606176)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9264420%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

title

Design & rationale of the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9264420%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

main subject

coronary artery disease

1 reference

1 reference

J R Downs

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9264420%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

P A Beere

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9264420%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

E Whitney

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9264420%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

M Clearfield

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9264420%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

S Weis

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9264420%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

J Rochen

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9264420%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

E A Stein

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9264420%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

D R Shapiro

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9264420%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

A Langendorfer

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9264420%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

A M Gotto

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9264420%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

language of work or name

English

0 references

publication date

1 August 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9264420%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Cardiology

5 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9264420%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

80

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9264420%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9264420%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

287-293

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9264420%20AND%20SRC:MED&resulttype=core&format=json

Cholesterol reduction in cardiovascular disease. Clinical benefits and possible mechanisms.

5 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900347-0

Cholesterol and mortality. 30 years of follow-up from the Framingham study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900347-0

Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900347-0

Range of serum cholesterol values in the population developing coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900347-0

A simple approximation for calculating sample sizes for comparing independent proportions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900347-0

The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900347-0

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900347-0

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900347-0

High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900347-0

Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900347-0

Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900347-0

The case for unstable angina pectoris as a primary end point in primary prevention studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900347-0

Changing presentation of coronary heart disease in an inpatient population within the U.S. military health care system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900347-0

Sheffield risk and treatment table for cholesterol lowering for primary prevention of coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900347-0

The cholesterol facts. A summary of the evidence relating dietary fats, serum cholesterol, and coronary heart disease. A joint statement by the American Heart Association and the National Heart, Lung, and Blood Institute. The Task Force on Cholester

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900347-0

Forum One: Current recommendations about intensification of metabolic control in non-insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900347-0

Protocol for a prospective collaborative overview of all current and planned randomized trials of cholesterol treatment regimens. Cholesterol Treatment Trialists' (CTT) Collaboration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900347-0

Group sequential designs using a family of type I error probability spending functions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900347-0

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9149(97)00347-0

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9264420%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference